![Aspirin for Primary Prevention of Cardiovascular Events in Relation to Lipoprotein(a) Genotypes - ScienceDirect Aspirin for Primary Prevention of Cardiovascular Events in Relation to Lipoprotein(a) Genotypes - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0735109722057205-fx1.jpg)
Aspirin for Primary Prevention of Cardiovascular Events in Relation to Lipoprotein(a) Genotypes - ScienceDirect
Stroke AHA/ASA on X: "#STROKE #ESOC2021 Untangling risks and benefits of #Ticagrelor + #aspirin vs. aspirin alone for mild stroke and high-risk TIA; Ischemic benefits (ARR=1.19%) outweigh hemorrhage risk (ARI=0.19%), resulting in
![Aspirin for the Primary Prevention of Cardiovascular Disease: Time for a Platelet-Guided Approach | Arteriosclerosis, Thrombosis, and Vascular Biology Aspirin for the Primary Prevention of Cardiovascular Disease: Time for a Platelet-Guided Approach | Arteriosclerosis, Thrombosis, and Vascular Biology](https://www.ahajournals.org/cms/asset/b8e58181-8c10-4d46-a114-99ddf25bf6ce/atvbaha.122.318020.fig06.jpg)
Aspirin for the Primary Prevention of Cardiovascular Disease: Time for a Platelet-Guided Approach | Arteriosclerosis, Thrombosis, and Vascular Biology
![VisualAbstract: Personalized Prediction of Cardiovascular Benefits and Bleeding Harms From Aspirin for Primary Prevention | 2 Minute Medicine VisualAbstract: Personalized Prediction of Cardiovascular Benefits and Bleeding Harms From Aspirin for Primary Prevention | 2 Minute Medicine](https://www.2minutemedicine.com/wp-content/uploads/2019/10/2MM_VA_9.29.2019_2.jpg)